Home » Newsletters » BioWorld

BioWorld

June 3, 2010

View Archived Issues

'Prolia' Blockbuster: Amgen Sets Premium Price in PMO

Amgen Inc.'s so-called "white knight" has stepped foot onto the battlefield. (BioWorld Today) Read More

Panel: MedImmune's New RSV Drug not Ready for 'Primetime'

Prophylactic Cancer Vaccine Could Usher in New Strategy

NewCo News: Sinapis Pharma Sees New Use for Meth in Stroke, Brain Injury

Other News To Note

Stock Movers

Financings Roundup

Clinic Roundup